Drugs / 18F-VM4-037
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00935142 | Jan → Nov 2012 | — | Maastricht Radiation Oncology | Withdrawn | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01712685 | Oct 2012 → Aug 2013 | renal cell carcinoma | National Cancer Institute (NCI) | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]VM4-037 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00935142 ↗ |
| Modality | Diagnostic / imaging agent | “hypoxia PET-tracer” NCT00935142 ↗ |
| Route | Intravenous | “via a bolus IV injection” NCT00935142 ↗ |